Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

  • There is currently no data for N4P

N4 Pharma Plc News

N4 Pharma outlines work plan after 'encouraging' data
25 Jan 2022

N4 Pharma outlines work plan after 'encouraging' data

(Sharecast News) - Specialist treatment and vaccine delivery system developer N4 Pharma updated the market on its work plan on Tuesday, following "enc...

IN BRIEF: N4 Pharma to focus resources on gene therapy
13 Dec 2021

IN BRIEF: N4 Pharma to focus resources on gene therapy

IN BRIEF: N4 Pharma to focus resources on gene therapy

N4 upbeat on cancer treatment progress, vaccine disappoints
13 Dec 2021

N4 upbeat on cancer treatment progress, vaccine disappoints

(Sharecast News) - Cancer treatment and vaccine delivery system developer N4 Pharma updated the market on data from its proof-of-concept programmes an...

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors
1 Nov 2021

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

N4 Pharma granted Europe patent with China equivalent on its way
1 Oct 2021

N4 Pharma granted Europe patent with China equivalent on its way

(Sharecast News) - Specialist pharmaceutical company N4 Pharma announced on Friday that it has been granted a patent for its 'Nuvec' cancer treatment ...

N4 Pharma secures patent in Europe for Nuvec, expects China to follow
1 Oct 2021

N4 Pharma secures patent in Europe for Nuvec, expects China to follow

N4 Pharma secures patent in Europe for Nuvec, expects China to follow

TRADING UPDATES: Christie Group and Open Orphan swing to profit
20 Sep 2021

TRADING UPDATES: Christie Group and Open Orphan swing to profit

TRADING UPDATES: Christie Group and Open Orphan swing to profit

TRADING UPDATES: Boku launches in Germany; Focusrite trading well
14 Sep 2021

TRADING UPDATES: Boku launches in Germany; Focusrite trading well

TRADING UPDATES: Boku launches in Germany; Focusrite trading well